i could not think of a better suitor, AGO is an absolute power house with no debt and a proven track record for making good acquisitions, i can see this being a perfect fit.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%